TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Herantis Pharma Oyj
Closing information (x1000 SEK)
| Closing information | 2016/12 (consolidated) | 2015/12 | 2013/12 |
| Turnover | 239 | 0 | |
| Financial expenses |
794
|
44,451
|
250 |
| Earnings before taxes |
-42,334
|
-141,474
|
-6,984 |
| Total assets |
97,630
|
131,005
|
23,618 |
| Current assets |
7,481
|
3,791
|
385 |
| Current liabilities |
5,865
|
3,426
|
5,992 |
| Equity capital |
15,068
|
97,361
|
1,073 |
| - share capital |
765
|
731
|
27 |
| Employees (average) |
7
|
5
|
3 |
Financial ratios
| Fiscal year | 2016/12 (consolidated) | 2015/12 | 2013/12 |
| Solvency |
15.4%
|
74.3%
|
4.5% |
| Turnover per employee | 34 | 0 | |
| Profit as a percentage of turnover | -17713.0% | ||
| Return on assets (ROA) |
-42.5%
|
-74.1%
|
-28.5% |
| Current ratio |
127.6%
|
110.7%
|
6.4% |
| Return on equity (ROE) |
-281.0%
|
-145.3%
|
-650.9% |
| Change turnover | |||
| Change turnover % | |||
| Chg. No. of employees | |||
| Chg. No. of employees % | 67% |
Total value of public sale
| Fiscal year | 2016/12 (consolidated) | 2015/12 | 2013/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.